meta|evidence COVID-19
  • Living systematic review and meta-analysis
  • ***** adjuvant therapies
  • anti-inflammatoty and immuno-therapy
  • anti-inflammatory therapies
  • Apilimod
  • corticosteroids
  • Immunostimulants drugs
  • Immunosuppressants drugs
  • inhaled corticosteroids
  • Kinase inhibitors
  • leflunomide
  • meplazumab
  • pirfenidone
  • Polyinosinic-Polycytidylic Acid
  • sargramostim
  • statins
  • thymosin
  • ***** antiandrogenic
  • ***** antiviral and associated therapy
  • ***** control
  • ***** Drugs for acid related disorders
  • ***** miscellaneous
  • ***** Oral antidiabetic drugs
  • ***** Renin-angiotensin-system-acting agents
  • ***** vaccines
  • ***** Vitamins
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 (hospitalized or not)
  • COVID-19 prophylaxis (children)
  • COVID-19 prophylaxis (excluding children)
  • infections other than COVID-19
  • Long COVID-19
  • preventing respiratory virus transmission
  • secondary prevention